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Introduction
The incidence of coliform mastitis has been on
the increase since a serious effort has been made
to eliminate Streptococcus agalactia and
Staphylacoccus auret.ts ma-mmary infections in dairy
herds throughout the U. S. As somatic cell coun;s
decrease in dairy cows, they tend to be more sus-
ceptible to coliform mastitis. It is likely that this
trend will continue as long as stringent controls are
being placed on somatic cell levels and premiums
are being offered for better quality milk.
"Coliform" is a general term for fermentative
gram-negative bacilli that inhabit the intestinal tract
of man and other animals normally without caus-
ing disease. These bacteria are classified within the
family Enterobacteriaceae. Certain members of this
group, Escherichia coli, Enterobacter aerogenes and
cloacoe, and Klebsiella have commonly been
isolated from bovine mastitis. 1 Coliforms are
ubiquitous in the cow's environment, but coliform
mastitis is not highly contagious. It is usually
described as an "environmental mastitis."
Cases of coliform mastitis are clinically described
as being peracute, acute, subacute, or subclinical.
Coliform organisms have been shown to be the
principle cause of peracute toxic mastitis. Eberhart
(1979) estimates that 10 to 15 percent of clinical
coliform cases are peracute. 1 It is commonly the
peracute case in which the cow is systemically
affected by endotoxin release, and it is this aspect
of the disease that will be discussed. Peracute cases
may result in loss offunction of the affected quarter,
agalactia affecting all quarters and, occasionally,
death of the cow. 2
Most coliform mastitis is seen during the peripar-
turient period or in early lactation. About two-thirds
of coliform mastitis cases are seen in the first three
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months of lactation. 1 Lactoferrin concentrations in
the dry cow secretions strongly inhibit active infec-
tion of the dry cow. 3,4 It is only when these con-
centrations decrease near calving that susceptibility
is greatly increased. The stress of calving also
increases conisolleveis which may be immunosup-
pressive and lead to increased susceptibility.
Although there are exceptions, most cases ofcoli-
form mastitis are due to bacterial invasion of the
mammary gland via the teat canal. Whether these
infections are established at drying off and remain
dormant, or whether infection occurs immediately
prior to the clinical crisis, the clinical signs and prog-
nosis are generally the same. This paper will review
the current ideas on diagnosis, pathogenesis, and
therapy of an animal experiencing endotoxic shock.
Diagnosis and Clinical Signs
The diagnosis of an endotoxic crisis from coli-
form mastitis is not always clear-cut. In most
instances, farmers are aware of the majority of the
systemic signs and can associate them with acute
mastitis. Dairymen are adept at noticing signs of
udder inflammation and abnormal milk secretion.
Difficulty may arise due to the sudden onset of
some cases. A cow may be normal at one milking
and severely ill before or at the next milking due
to rapid multiplication of bacteria followed by
release and dissemination of endotoxin. 1
Another situation in which there may be
difficulty in diagnosing a peracute case is when
systemic signs of illness precede any detectable
evidence of mastitis. In these instances, udder
inflammatory changes may lag behind systemic
effects by several hours.
The history often shows sudden onset of anorexia,
fever, depression, shivering, and rumen stasis.
Inflammatory signs in the udder may be minimal
at this time and swelling may be detectable only
after the quarter is milked out. Later, the quarter
is swollen and hard. In some instances, the affect-
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ed quaner may be smaller than the others due to
hypogalactia. 1
Signs of endotoxic shock may appear within a few
hours of onset. These include recumbency, marked
depression, progressive dehydration, diarrhea, nor-
mal or subnormal temperatures, raised pulse and
respiratory rates, diminished papillary response,
dark toxic mucous membranes and cold extremi-
ties. At this time, the prognosis is guarded to poor.
The signs of intoxication due to peracute
intramammary infection must be differentiated
from signs of other severe systemic diseases such as
parturient paresis, metritis, and ketosis. One must
remember that the cow may be concurrently
hypocalcemic because of the coliform infection. 5,6
Weakness and recumbency in recently calved cows
resembles parturient paresis, but dehydration and
diarrhea, if present, are not characteristic of
parturient paresis and should prompt a further clin-
ical examination, particularly of the udder.
The definitive diagnosis of the causative agent
is not pertinent at this point beyond its suscepti-
bility to certain antimicrobial agents. The severe
systemic signs that are exhibited do not allow delay-
ing therapy until positive culture results are avail-
able. One should apply systemic support while
administering an antimicrobial agent that is either
broad spectrum or has a history of clinical effective-
ness in similar situations. Culture results can be a
retrospective aid for treatment and prevention of
future cases demonstrating similar clinical signs.
Pathogenesis
The pathogenesis of endotoxic shock associated
with coliform mastitis is complex and controversial.
It is agreed that endotoxin is the mediator of the
severe systemic signs. The effects of endotoxins are
varied and often profound. The severity of these
changes are dose and rate dependent. Suprisingly,
endotoxins appear to have relatively little direct toxic
effect; most of the severe changes are indirect,
associated with cascades of biologic processes initiat-
ed by endotoxin.7
The term endotoxin refers to a part of the cell
wall or envelope of gram-negative bacteria. It is
synonymous with the 0 antigen, or somatic anti-
gen, of these bacteria and is composed of poly-
saccharides, phospholipids, and small amounts of
protein. These compounds are referred to as
endotoxins, lipopolysaccharides, or endotoxic phos-
pholiposaccharides. 8
Endotoxin release from bacteria is commonly
attributed to lysis of the organisms by phagocytes.
However, it is important to note that endotoxin
may be released from cells during active growth as
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well as by celllysis. l,9,lo Schalm, et al,l1 postulat-
ed that destruction of the bacteria by these phago-
cytes causes release of the endotoxin which increases
vascular permeability, and causes a subsequent
influx of serum factors into the milk. Jain, et aI,l1
concluded that one function of the neutrophil is
to initiate the events leading to vascular permeabil-
ity. The neotrophils and their lysosomes will then
mediate the production of the cardinal signs of in-
flammation, pain, swelling and hyperthermia. A
number of researchers have suggested that the
accompanying severe systemic signs may be due
to anaphylactic shock in response to the endo-
toxin. l,l2
The existance of endotoxemia is the most con-
troversial subject in the pathogenesis of endotoxic
mastitis. Absorption of the endotoxin into the
blood from the mammary gland has been demon-
strated. l3 It appears that endotoxin is cleared more
quickly from the blood than from the milk. This
result suggests that endotoxin is detoxified rapidly
after absorption into the circulation. l
Some investigators seriously doubt that the clin-
ical signs ofgeneralized disease in these animals may
be caused by absorption of endotoxin by the
udder. l4,l5 They contend that systemic signs are
predominantly due to the formation of endogenous
mediators in the inflamed udder and their subse-
quent release into the circulation. l4 ,l5
It seems reasonable that endotoxin within the ud-
der causes formation of endogenous mediators in
the gland. These mediators cause increased vascu-
lar permeability which may allow for systemic dis-
tribution of endotoxin. It seems reasonable that
most of the mediator production initiated by the
endotoxin would take place in the udder where a
high concentration of leukocytes and endotoxin are
in contact. It is doubtful that endotoxin which gains
access to the general circulation would be signifi-
cant in comparison to the massive mediator produc-
tion taking place within the mammary gland.
Increased vascular permeability is the initial event
in the chain of reactions involved in endotoxin-
induced peracute mastitis. The release of endogen-
ous mediators such as histamine, serotonin, serum
permeability factors, bradykinin, and kallikrein may
be responsible for the increased vascular permea-
bility in the early phase of mastitis.4,5
Bacteremia associated with coliform mastitis plays
little role in the pathogenesis and, in fact, is un-
common. Powers, et al,l7 concluded that less than
15 percent of cows with pure or mixed toxic gram-
negative mastitis had a gram-negative bacteremia.
Histamine is released from cells damaged directly
bv endotoxin and indirectly by the effects of inflam-
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mation and ischemia associated with shock. Hista-
mine appears to be the major factor responsible for
early phases of circulatory shock. I8 It plays a very
minor role in the pathogenesis of endotoxic cardi-
0vascular shock relative to other factors after the fust
several hours. I9
Arachidonic acid metabolites (AAM) are among
the many biological compounds implicated in the
mediation of acute inflammation.2o,21 The AAM,
including stable prostaglandins, thromboxanes and
prostacyclin, are produced when the multienzyme
cyclooxygenase complex acts on arachidonic acid
released from cell membranes during inflamma-
tion. 20 ,21 AAM appear to be involved in media-
tion of the local mammary inflammation and
systemic signs observed in acute coliform mastitis.
Nonsteroidal anti-inflammatory agents inhibit the
multienzyme cyclooxygenase compiex. 20,21 ,22
The changes in glucose metabolism during an en-
dotoxic crisis have been described by McClure
(1976).19 Early hyperglycemia is caused by endo-
toxin activation of hepatic membrane-bound
enzymes that stimulate glycogenolysis and subse-
quent release of glucose to the blood stream. A
secondary hypoglycemia rapidly develops. Liver
glycogen is depleted as glycogenolysis continues and
as endotoxin inhibits replenishment production of
more hepatic glycogen. Hepatic gluconeogenesis is
also depressed as endotoxin inhibits enzymes that
catalyze glucocorticoid activation of the process and
induces high levels of circulating insulin that direct-
1y antagonizes it. The characteristic cardiovascular
insufficiency results in ischemic tissues that require
increased amounts of glucose for metabolism. This
increased need for glucose in the face of
hypoglycemica results in cell dysfunction and death.
Only a few cases have been documented in
regards to disseminated intravascular coagulation
(DIe) in cows, although many deaths associated
with endotoxic mastitis probably incorporate some
degree of DIC. The inciting factors triggering the
development ofDIC are a response to an underly-
ing illness, provoking a generalized activation of the
hemostatic mechanisms. The usual hemostatic
response is confined to an area of local vascular in-
jury, but DIC is widespread, depleting fibrinogen
and other clotting factors with activation of the
fibrinolytic systems. 23
Peracute coliform infections in cows may produce
a hypocalcemic syndrome clinically resembling par-
turient paresis. 1 There is debate as to whether these
are concurrent milk fever cases independent of the
endotoxic mastitis or a direct result of endotoxin
release. The pathogenesis of changes in serum cal-
cium are not understood at this time, but are postu-
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lated to be due to decreased intestinal absorption
following endotoxin-induced alimentary stasis6 and
possible endotoxin-mediated humoral factors.'
Prognosis
The prognosis for a peracute case of coliform
mastitis is always guarded and often poor for recov-
ery of both the cow and the mammary gland.
The animal with endotoxemia responds in at least
two critical ways. The first way is to clear the
organism, and the second is to clear the endotoxin
without setting off an immunologic cascade of over-
reaction, which may itself destroy the animal. Con-
trary to the usual thoughts about response to
infection, the response to endotoxin must be Ii-mit-
ed if the animal is to survive.8 This type of over-
reaction is exemplified by those animals developing
disseminated intravascular coagulation. 23
If the cow does not die acutely, a protracted ill-
ness with poor appetite and progressive weight loss
may ensue. 24 Bushnell estimated that 10 percent
of cows with peracute coliform mastitis died, 70 per-
cent became agalactic and 20 percent returned to
milk. Cows that became agalactic often returned
to normal production in subsequent lactations. 25
The outcomes of severe coliform cases were re-
cently studied. 26 Among 88 affected cows, all of
which received appropriate therapy, 7- percent died
as a result of the infection and an additional 17 per-
cent were culled during the lactation. In 11 per-
cent of the cases, the cow was retained in the herd
but the affected quarter did not return to milk in
that lactation. Half of these agalactic quarters secret-
ed milk in the subsequent lactation, but the other
half did not. In 59 percent of all cases, the quarter
secreted normal-appearing milk during the lacta-
tion in which mastitis occurred. From these data,
it appears that most cows with severe coliform
infection do recover, but nearly 24 percent will
either die or be culled as a direct result of the in-
fection. 2 Fortunately, peracute cases comprise only
a small proportion, perhaps 10 percent of all
coliform infections. 25
Successful therapy is dependent on a number of
factors including the following: dose of endotoxin
encounterd, immune status of the animal, condi-
tion of the animal when therapy was initiated,
intensity of therapeutic procedures, and proper
selection of therapeutic agents. The economic value
of the animal must be considered when determin-
ing the duration ofcostly therapy, especially in view
of the guarded prognosis regardless of therapy.
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Therapy
All cases of peracute coliform mastitis should be
treated promptly and aggressively. The sooner ther-
apeutic measures are initiated, the better the prog-
nosis will be. Dairymen should not attempt to treat
these cases alone, nor should they hesitate in call-
ing a veterinarian.
By remembering the main therapeutic goals of
removing bacteria and limiting the immune cas-
cade set off by endotoxins, treatment can be
approached rationally. 0 bjectives for mastitis
therapy are to preserve the life of the animal, restore
function to the mammary gland, and improve the
quality and efficiency of production. Specific
therapeutic measures are directed at removal of
causative agent, detoxification and support for
systemically affected animals, reduction and elimi-
nation of toxic waste products, and promotion of
healing of damaged tissue.
A. Antimicrobial Therapy
Antimicrobial drugs are used to reduce the
production of endotoxin. Selection of the proper
drug can sometimes be very difficult. In toxic cases,
one cannot wait for an etiological diagnosis.
Immediate therapy with either a broad spectrum
agent or one that has shown clinical effectiveness
in the past is necessary. Commonly used agents are
sulfonamides, gentamycin, oxytetracycline, and
lincomycin/ spectinomycin combinations. The
choice of the appropriate antimicrobial agent is
influenced by a number of considerations includ-
ing the drug's spectrum of activity, toxicity, con-
venience of administration, withdrawal time, and
cost. 2
Systemic administration of appropriate drugs
supplemented by intramammary infusion is usually
recommended. 1 Polymyxins (polymyxin B and
colistin) are narrow spectrum polypeptide antibiotics
sometimes used for intramammary treatment. The
unique property of these drugs is that they neu-
tralize endotoxin in vitro27 and in vivo. 28 Another
study indicated that they inactivate toxins in vitro
but that there was little clinical evidence to recom-
mend use.9
B. Removal of Bacteria and Toxins
The importance of frequent stripping of affect-
ed quarters to remove toxins cannot be over-
emphasized. This procedure may save the quarter
and will reduce the amount of toxins in the sys-
tem. Stripping the quarter at 1 to 2 hour intervals
gives the best results. Simultaneous use of 10-30
units ofoxytocin allows for better clearance ofwaste
products. Antibiotics should be placed in the quart-
er after the last milkout at night. 1
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C. Fluid Therapy
In peracute cases where systemic signs are ex-
hibited, fluid therapy can be life-saving.
Intravenous balanced electrolyte solutions reverse
hypotension and increase cardiac output. They also
help to maintain renal perfusion and allow diuresis
of toxic metabolites. Up to 20 liters should be given
in the fust 1 to 2 hours. The remainder of the total
dose (60 to 110 ml per kg BW) may be given over
the next 10-12 hours. 2 Oral fluids may be benefi-
cial in some cases and are commonly implemented
in recovery stages.
D. Corticosteroids
Corticosteroids tend to neutralize the effects of
inflammation and endotoxic shock. Both a high
dose- of IV dexamethasone (40-80mg/1OOkg BW)
administered only once and another treatment
repeated after 8-12 hours have been shown to be
beneficial. 1 The disadvantage of corticosteroids is
that they tend to be immunosuppressive and in-
hibit bacterial clearance. Use ofsteroids has largely
been replaced by nonsteroidal, anti-inflammatory
drugs such as flunixin meglumine.a
E. Nonsteroidal Anti-inflammatory Agents
Arachidonic acid metabolites are responsible for
mediation of acute inflammation. They are
produced through the multienzyme cyclooxygenase
complex, and nonsteroidal anti-inflammatory
agents inhibit the complex. These agents are there-
fore indicated for treatment of peracute toxic
mastitis.
The most widely used agent is flunixin meglu-
mine at 0.5 mg/ lb IV. 16 Oral doses of aspirin may
be effective at 100 mg/kg (0.67-1 gr/lb) BID,29 and
phenylbutazone may be given at 4-8 mg/kg orally
or 2-5 mg/kg IV.30
F. Glucose Therapy
Many of these animals are hypoglycemic due to
effects of endotoxin. They may benefit from
intravenous glucose administration. Usually, 250g
of glucose is adequate. A 500 ml of 50% glucose
solution can also be added the first 5-10 liters of
fluid given N.31
G. Calcium Therapy
Intravenous calcium boro-gluconate has reversed
the signs ofhypocalcemia in both experimental cases
of endotoxemia and clinical cases of peracute coli-
form mastitis.6 Extreme care must be taken when
administering calcium to a toxic cow. Endotoxin
AAM and catecholamines all sensitize the myocardi-
aBanamineR (flunixin meglumine) Schering Corp., Kenilwonh,
N]
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urn to calcium. Calcium therapy may be safer if
delayed until after initial volume expansion with
fluids or if administered subcutaneously.
H. Antihistamines
According to Allenstein (1977), antihistamines
are of empirical value if administered repeatedly
every 3 to 4 hours for at least 2 days.32 Histamine
appears to be the major factor responsible for the
early phase of circulatory shock. It also plays a very
minor role in the pathogenesis relative to other fac-
tors after the first several hours. 19
I. Heparin
In cases where one suspects that DIC is a pos-
siblity, heparin may be given at 75 IV/kg BW
(56,000 units)/day.23
Conclusion
Peracute toxic mastitis is a very frustrating disease
to treat. Coliform organisms are ubiquitous in the
cow's environment, and coliform mastitis does not
respond to control measures as do gram positive
infections. Therefore, it is likely the dairy industry
will be living with this disease for some time to
come. Clinically affected animals must be aggres-
sively treated if endotoxic shock is to be reversed
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